StockNews.com upgraded shares of Greenlight Capital Re (NASDAQ:GLRE – Free Report) from a hold rating to a buy rating in a research report released on Wednesday morning.
Greenlight Capital Re Stock Down 0.3 %
Greenlight Capital Re stock traded down $0.04 during mid-day trading on Wednesday, hitting $12.47. The company’s stock had a trading volume of 85,593 shares, compared to its average volume of 76,190. The firm’s 50 day moving average is $12.92 and its 200 day moving average is $12.48. Greenlight Capital Re has a 52-week low of $10.45 and a 52-week high of $13.96. The company has a market cap of $440.45 million, a PE ratio of 4.17 and a beta of 0.84. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.09 and a quick ratio of 3.09.
Greenlight Capital Re (NASDAQ:GLRE – Get Free Report) last issued its earnings results on Tuesday, August 6th. The financial services provider reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.02). Greenlight Capital Re had a net margin of 15.69% and a return on equity of 18.32%. The firm had revenue of $174.86 million during the quarter.
Institutional Inflows and Outflows
Greenlight Capital Re Company Profile
Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. The company offers various property reinsurance products and services, including automobile physical damage, personal lines, and commercial lines. It also provides casualty reinsurance products and services comprising general liability, motor liability, professional liability, and worker's compensation; and accident and health, transactional liability, mortgage insurance, surety, trade credit, marine, and energy, as well as other specialty products, such as aviation, crop, cyber, political, and terrorism products.
Featured Stories
- Five stocks we like better than Greenlight Capital Re
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 8/5 – 8/9
- What is MarketRank™? How to Use it
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- How to Invest in the Best Canadian Stocks
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for Greenlight Capital Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenlight Capital Re and related companies with MarketBeat.com's FREE daily email newsletter.